Medigene AG
MDGEF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $30,666 | $47,829 | $65,396 | $84,760 |
| - Cash | $8,674 | $22,224 | $22,417 | $30,033 |
| + Debt | $2,950 | $3,726 | $4,024 | $5,154 |
| Enterprise Value | $24,942 | $29,331 | $47,003 | $59,881 |
| Revenue | $6,034 | $31,247 | $10,463 | $8,002 |
| % Growth | -80.7% | 198.6% | 30.8% | – |
| Gross Profit | $4,391 | $7,412 | $5,675 | $238 |
| % Margin | 72.8% | 23.7% | 54.2% | 3% |
| EBITDA | -$15,445 | $13,112 | -$6,511 | -$21,532 |
| % Margin | -256% | 42% | -62.2% | -269.1% |
| Net Income | -$16,177 | -$8,330 | -$9,983 | -$28,875 |
| % Margin | -268.1% | -26.7% | -95.4% | -360.8% |
| EPS Diluted | -1.32 | -0.64 | -0.77 | -2.23 |
| % Growth | -106.3% | 16.9% | 65.5% | – |
| Operating Cash Flow | -$15,119 | $11,976 | -$10,754 | -$24,786 |
| Capital Expenditures | -$664 | -$1,007 | -$125 | -$484 |
| Free Cash Flow | -$15,783 | $10,969 | -$10,879 | -$25,270 |